Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
52.1M
-
Shares change
-
+405K
-
Total reported value, excl. options
-
$166M
-
Value change
-
+$896K
-
Put/Call ratio
-
0.4
-
Number of buys
-
47
-
Number of sells
-
-56
-
Price
-
$3.18
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q3 2023
129 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q3 2023.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.1M shares
of 127M outstanding shares and own 41.06% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (12.3M shares), MORGAN STANLEY (6.94M shares), BlackRock Inc. (4.95M shares), VANGUARD GROUP INC (3.7M shares), ACADIAN ASSET MANAGEMENT LLC (2.59M shares), GEODE CAPITAL MANAGEMENT, LLC (1.63M shares), AQR CAPITAL MANAGEMENT LLC (1.54M shares), MILLENNIUM MANAGEMENT LLC (1.32M shares), STATE STREET CORP (1.31M shares), and D. E. Shaw & Co., Inc. (1.09M shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.